The table below shows CollPlant Biotechnologies Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2025
Q2 2024
Q2 2023
Q2 2022
Q2 2021
Q2 2020
Revenue
$179.00K
$249.00K
$10.18M
$66.00K
$691.00K
$823.00K
Cost of revenue
$186.00K
$536.00K
$615.00K
$43.00K
$429.00K
$748.00K
Gross profit
-$7.00K
-$287.00K
$9.57M
$23.00K
$262.00K
$75.00K
R&D
$2.01M
$2.70M
$2.57M
$2.60M
$1.90M
$1.00M
CLGN annual revenue (10-K history)
CollPlant Biotechnologies Ltd reported annual revenue of $2.37M for fiscal year 2025. That is up 360.4% from $515.00K in fiscal 2024. Over the 8 fiscal years shown, annual revenue declined from $5.01M (FY 2018) to $2.37M. Figures come from the company's audited annual reports as filed with the SEC.